Searched for: in-biosketch:true
person:segevd01
Replacing Unintentional Weight Loss with CT-Assessed Sarcopenia in the Physical Frailty Phenotype for Kidney Transplant Recipients [Meeting Abstract]
Chen, Xiaomeng; Shafaat, Omid; Liu, Yi; King, Elizabeth; Weiss, Clifford; Xue, Qian-Li; Walston, Jeremy; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700120
ISSN: 1600-6135
CID: 5133642
Perception of Transplant Surgery and the Pursuit of a Career in Transplant Surgery Among US General Surgery Residents [Meeting Abstract]
Loseth, Caitlin; Qin, Caroline; Zeiser, Laura; Segev, Dorry; Dageforde, Leigh Anne; Watkins, Anthony; Collins, Kelly; Glorioso, Jaime; Quillin, R. Cutler, III; Garonzik-Wang, Jacqueline; Tevar, Amit
ISI:000739470700138
ISSN: 1600-6135
CID: 5133652
Facilitating Education and Advocacy Training to Expand Live Donor Kidney Transplantation in the setting of the COVID-19 pandemic: Experience with the ENGAGE Multi-center Trial [Meeting Abstract]
Mitchell, Jonathan; Lopez, Julia; Nijhar, Kieranjeet; Zeiser, Laura Bowles; Chiang, Teresa; King, Elizabeth; Segev, Dorry; Cameron, Andrew
ISI:000739470700146
ISSN: 1600-6135
CID: 5133662
Characterizing the early impact of the Kidney Accelerated Placement Project on hard-to-place kidneys [Meeting Abstract]
Motter, Jennifer; Kernodle, Amber; Gentry, Sommer; Levan, Macey; Wood, Nicholas; Segev, Dorry; Garonzik-Wang, Jacqueline; Massie, Allan
ISI:000739470700152
ISSN: 1600-6135
CID: 5133672
Long-term Frailty Trajectories After Kidney Transplantation [Meeting Abstract]
Ruck, Jessica; Chu, Nadia; Chen, Xiaomeng; Bandeen-Roche, Karen; Norman, Silas; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700169
ISSN: 1600-6135
CID: 5133682
Increased Logistical Complexity In Circle-Based Organ Allocation [Meeting Abstract]
Wood, Nicholas; VanDerwerken, Douglas; Segev, Dorry; Gentry, Sommer
ISI:000739470700198
ISSN: 1600-6135
CID: 5133692
Opportunities for Improved Efficiency in Kidney Distribution: A Comparison of Center-Specified UNet Donor Criteria to Actual Kidney Acceptance Practices [Meeting Abstract]
Zeiser, Laura; Gentry, Sommer; Segev, Dorry; Massie, Allan
ISI:000739470700207
ISSN: 1600-6135
CID: 5133702
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
Frey, Sarah; Chiang, Teresa Po-Yu; Connolly, Caoilfhionn M; Teles, Mayan; Alejo, Jennifer L; Boyarsky, Brian J; Christopher-Stine, Lisa; Werbel, William A; Massie, Allan B; Segev, Dorry L; Paik, Julie J
PMCID:8765758
PMID: 35072108
ISSN: 2665-9913
CID: 5127932
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
Lai, Jennifer C; Shui, Amy M; Duarte-Rojo, Andres; Ganger, Daniel R; Rahimi, Robert S; Huang, Chiung-Yu; Yao, Frederick; Kappus, Matthew; Boyarsky, Brian; McAdams-Demarco, Mara; Volk, Michael L; Dunn, Michael A; Ladner, Daniela P; Segev, Dorry L; Verna, Elizabeth C; Feng, Sandy
BACKGROUND AND AIMS/OBJECTIVE:Frailty is a well-established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it predicts outcomes among those who have undergone LT is unknown. APPROACH AND RESULTS/UNASSIGNED:Adult LT recipients from 8 US centers (2012-2019) were included. Pre-LT frailty was assessed in the ambulatory setting using the Liver Frailty Index (LFI). "Frail" was defined by an optimal cut point of LFI ≥ 4.5. We used the 75th percentile to define "prolonged" post-LT length of stay (LOS; ≥12 days), intensive care unit (ICU) days (≥4 days), and inpatient days within 90 post-LT days (≥17 days). Of 1166 LT recipients, 21% were frail pre-LT. Cumulative incidence of death at 1 and 5 years was 6% and 16% for frail and 4% and 10% for nonfrail patients (overall log-rank p = 0.02). Pre-LT frailty was associated with an unadjusted 62% increased risk of post-LT mortality (95% CI, 1.08-2.44); after adjustment for body mass index, HCC, donor age, and donation after cardiac death status, the HR was 2.13 (95% CI, 1.39-3.26). Patients who were frail versus nonfrail experienced a higher adjusted odds of prolonged LT LOS (OR, 2.00; 95% CI, 1.47-2.73), ICU stay (OR, 1.56; 95% CI, 1.12-2.14), inpatient days within 90 post-LT days (OR, 1.72; 95% CI, 1.25-2.37), and nonhome discharge (OR, 2.50; 95% CI, 1.58-3.97). CONCLUSIONS:Compared with nonfrail patients, frail LT recipients had a higher risk of post-LT death and greater post-LT health care utilization, although overall post-LT survival was acceptable. These data lay the foundation to investigate whether targeting pre-LT frailty will improve post-LT outcomes and reduce resource utilization.
PMID: 34862808
ISSN: 1527-3350
CID: 5127772
After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law
Levan, Macey L; Reich, David J; Segev, Dorry L L
PMCID:8678179
PMID: 34342961
ISSN: 1534-6080
CID: 5127472